NCT05894317Completed
Vascular Access Complications for Therapeutic Apheresis in Nephrology
Vascular Access Complications for Therapeutic Apheresis in Nephrology : a Retrospective Observational Study in North-East France.
Source: ClinicalTrials.gov · Last updated 24 Feb 2025
Brief summary (registry, in English)
The aim of this study is to describe vascular access complications which are used for therapeutic apheresis in Nephrology.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 60 (actual)
- First submitted
- 30 May 2023
- Start date
- 1 Jun 2020
- Primary completion date
- 30 Jun 2022
- Lead sponsor
- Central Hospital, Nancy, France
- Diseases
- ANCA-associated vasculitis
- NCT number
- NCT05894317
What you commit to
- Study type: Observational
- Participants enrolled: 60
- From 1 Jun 2020 to the primary completion date, 30 Jun 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- apheresis treatment for other indications
- centrifugation apheresis treatment
Who the study is looking for
- patients in nephrology receiveing apheresis treatment by filtration or double filtration
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Central Hospital Coordinator of this site? Confirm its status | Nancy | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.